Primary Job Title Board Member Primary Organization 
MTS Medication Technologies
Gender Male
Stanley Blaylock is the Board Director at SoloHealth Inc.
Stanley Blaylock began his career in healthcare investment banking, where he rose to the Global Co-Head of Health Care Investment Banking at Deutsche Bank.
Blaylock went on to co-found specialty pharmacy solutions company Medmark, which quickly became one of the most rapidly growing
companies in the healthcare services industry; he served as its Executive Vice President/Chief Financial Officer and Chief Administrative Officer until his promotion to President and Chief Executive in 2005.
When Walgreens acquired Medmark in 2006, Blaylock joined the company, and through a series of quick promotions, became Walgreens Senior Vice President and President of Walgreens Health Services. During his approximately four years at Walgreens, he successfully integrated Medmark, driving Walgreens Specialty Pharmacy to the #3 player in the industry through rapid internal growth and key strategic acquisitions.
Blaylock earned a Degree in Economics & Communication studies, graduating Phi Beta Kappa with Highest Distinction, from the University of Virginia in 1989.
He received the Duncan Clark Hyde award as the most outstanding economics major.
He received his master's degree in business administration from Harvard Business School in 1989.
He is also a 2009 fellow of the CEO Perspective Program from Northwestern's Kellogg School of Management and Corporate Leadership Center.
Blaylock currently serves on the Board of Directors of NovaSom, Inc., a leading provider of home sleep testing services for obstructive sleep apnea.
He is also a member of the Board of Directors of MTS Medication Technologies, an international provider of adherence packaging systems, designed to improve medication dispensing and administration.
